Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Zalcberg

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
International Journal of Colorectal Disease|November 16, 2018
Correction to: Short-term outcome of emergency colorectal cancer surgery: results from Bi-National Colorectal Cancer AuditChun Hin Angus Lee, Joseph Cherng Huei Kong, Alexander G Heriot, et al.
The Lancet Regional Health. Western Pacific|April 17, 2025
Informing health system planning for biomarker-based treatment: statistical prevalence projections for solid cancers with key pan-tumour biomarkers (dMMR, MSI, high TMB) in Australia to 2042Yoon-Jung Kang, Qingwei Luo, Joachim Worthington, et al.
Asia-Pacific Journal of Clinical Oncology|August 6, 2013
Registry of gastric cancer treatment evaluation (REGATE): II treatment practiceMikhail Ter-Ovanesov, Suayib Yalcin, John Zalcberg, et al.
International Journal of Colorectal Disease|October 1, 2018
Short-term outcome of emergency colorectal cancer surgery: results from Bi-National Colorectal Cancer AuditChun Hin Angus Lee, Joseph Cherng Huei Kong, Alexander G Heriot, et al.
Asia-Pacific Journal of Clinical Oncology|August 14, 2013
Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristicsYung-Jue Bang, Suayib Yalcin, Arnaud Roth, et al.
Scientific Reports|November 28, 2022
A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumoursYoon-Jung Kang, Sophie O'Haire, Fanny Franchini, et al.
Journal of Pharmaceutical Policy and Practice|August 23, 2024
Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year reviewSenthil Lingaratnam, Safeera Yasmeen Hussainy, Alexandra Murphy, et al.
American Journal of Cancer Research|March 9, 2022
Systematic review of the predictors of health service use in pancreatic cancerNadia N Khan, Tennille Lewin, Amy Hatton, et al.
British Journal of Cancer|August 6, 2019
Challenges of international oncology trial collaboration-a call to actionMonica Tang, Heikki Joensuu, Robert J Simes, et al.
European Journal of Cancer Care|May 6, 2022
The SYMPTOM-upper gastrointestinal study: A mixed methods study exploring symptom appraisal and help-seeking in Australian upper gastrointestinal cancer patientsNapin Karnchanachari, Shakira Milton, Tjuntu Muhlen-Schulte, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
International Journal of Colorectal Disease|November 16, 2018
Correction to: Short-term outcome of emergency colorectal cancer surgery: results from Bi-National Colorectal Cancer AuditChun Hin Angus Lee, Joseph Cherng Huei Kong, Alexander G Heriot, et al.
The Lancet Regional Health. Western Pacific|April 17, 2025
Informing health system planning for biomarker-based treatment: statistical prevalence projections for solid cancers with key pan-tumour biomarkers (dMMR, MSI, high TMB) in Australia to 2042Yoon-Jung Kang, Qingwei Luo, Joachim Worthington, et al.
Asia-Pacific Journal of Clinical Oncology|August 6, 2013
Registry of gastric cancer treatment evaluation (REGATE): II treatment practiceMikhail Ter-Ovanesov, Suayib Yalcin, John Zalcberg, et al.
International Journal of Colorectal Disease|October 1, 2018
Short-term outcome of emergency colorectal cancer surgery: results from Bi-National Colorectal Cancer AuditChun Hin Angus Lee, Joseph Cherng Huei Kong, Alexander G Heriot, et al.
Asia-Pacific Journal of Clinical Oncology|August 14, 2013
Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristicsYung-Jue Bang, Suayib Yalcin, Arnaud Roth, et al.
Scientific Reports|November 28, 2022
A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumoursYoon-Jung Kang, Sophie O'Haire, Fanny Franchini, et al.
Journal of Pharmaceutical Policy and Practice|August 23, 2024
Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year reviewSenthil Lingaratnam, Safeera Yasmeen Hussainy, Alexandra Murphy, et al.
American Journal of Cancer Research|March 9, 2022
Systematic review of the predictors of health service use in pancreatic cancerNadia N Khan, Tennille Lewin, Amy Hatton, et al.
British Journal of Cancer|August 6, 2019
Challenges of international oncology trial collaboration-a call to actionMonica Tang, Heikki Joensuu, Robert J Simes, et al.
European Journal of Cancer Care|May 6, 2022
The SYMPTOM-upper gastrointestinal study: A mixed methods study exploring symptom appraisal and help-seeking in Australian upper gastrointestinal cancer patientsNapin Karnchanachari, Shakira Milton, Tjuntu Muhlen-Schulte, et al.
Pageof 15